Auna S.A. logo

Auna S.A.(AUNA)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$4.59
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for AUNA

11/13/2026: AUNA (1-star) is currently NOT-A-BUY. Pass it for now.

Auna S.A. is a Latin American healthcare operator running hospital networks and prepaid medical plans across Peru, Colombia, and Mexico. The company's primary strength lies in its vertically integrated Oncosalud oncology business in Peru, which generates stable cash flows. Its main growth opportunity stems from expanding ambulatory networks and capturing rising demand for private healthcare. However, heavy balance sheet debt and operational underperformance in Mexico present notable risks. The stock suits risk-tolerant growth investors willing to monitor debt reduction and operational turnarounds across emerging markets.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitWhile Peru operations exhibit steady growth, contraction in Mexico weighs on consolidated expansion.
Momentum investorWeak fitThe stock lacks sustained upward price momentum, making it conditional on a positive technical upturn signal.
Value investorMixed fitLow forward earnings multiples are counterbalanced by heavy balance sheet leverage and debt risks.
Dividend investorWeak fitThe company does not pay dividends, focusing instead on capital deployment and debt service.
Low-risk investorWeak fitHigh financial leverage, currency exposure, and regional volatility create substantial risk.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highThe stock experiences notable price swings characteristic of small-cap emerging market listings.
Valuation riskMediumLow earnings multiples reflect discounted pricing due to underlying structural concerns.
Competition risk (regional hospital and managed-care competition)HighAuna competes against deeply entrenched local hospital networks in fragmented markets like Mexico.
Business qualityMediumThe Oncosalud franchise is high quality, but dragged down by weaker performance in international subsidiaries.
Dividend incomeLow / noneNo dividend distributions are currently offered to shareholders.
Execution riskHighSuccessfully turning around operations in Mexico and managing heavy debt obligations requires flawless execution.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 339.92M USD
Price to earnings Ratio 76.5
1Y Target Price 6.99
Price to earnings Ratio 76.5
1Y Target Price 6.99
Volume (30-day avg) 180.1K shares
Beta 0.66
52 Weeks Range 4.09 - 6.29
Updated Date 11/15/2026
52 Weeks Range 4.09 - 6.29
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.06

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Care Facilities

BUY participation
88.9%
Active BUY / eligible
8 / 9
30-Day BUY Count Change
+6

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Downtrend
PRICE PATH

Downtrend

The stock has experienced a sustained decline in price over recent periods.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit -48.41%
Avg. Invested days 28
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
AUNA receives a 3-star rating, supported by solid analyst coverage. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
AUNA has moderate overall fundamentals (3 stars), with moderate financial health, soft growth momentum, and solid ownership. In FY2025 versus FY2024, growth and ownership metrics are mixed: negative earnings growth (-11.5%), soft cash generation (FCF margin 3.7%), slightly negative revenue growth (-0.0%).

Financial Health Rating

★★★★★
AUNA's financial health is supported by solid cash strength, including free-cash-flow generation (3.7% of revenue). Profitability is moderate (3 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
AUNA's growth profile is soft, with the least-weak measure being revenue growth at -0.0% FY2025 versus FY2024. By comparison, while earnings growth (-11.5%, negative) and free-cash-flow growth (-72.0%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 78.6% and approximately 91.0% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 3.97% provides only moderate management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 1.51%
Morgan Stanley - Brokerage Accounts 0.78%
Jane Street Group LLC 0.78%
Renaissance Technologies Corp 0.73%
Marshall Wace Asset Management Ltd 0.65%

Unit Economics (Per $1K Revenue)

★★★★★
AUNA generates approximately $379 of gross profit, $144 of operating income, and $37 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Soft margins and moderate cash conversion support a 3-star rating, while capital efficiency is soft.

Economic Dimensions

★★★★★
Effective Tax Rate: 44.34%

Quantitative Style Profile

★★★★★
AUNA has a liquid, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedLow VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Oncosalud Peru (Managed Care)Recurring membership premiums collected for prepaid oncology plans and specialized cancer care.Provides stable, predictable subscription-like cash flows from health plan members.
Healthcare Services (Peru, Colombia, Mexico)Revenues from inpatient hospital stays, surgeries, emergency room visits, and outpatient clinics.Generates revenue fee-for-service through physical medical infrastructure and patient care.
Ancillary Services & InsuranceSales of dental and vision insurance plans alongside pharmaceutical dispensing.Offers diversified supplementary revenue streams outside core hospital operations.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-11-17
When After Market
Estimate 0.27
Actual -

Profitability

Profit Margin 0.35%
Operating Margin (TTM) 13.39%

Management Effectiveness

Return on Assets (TTM) 5.22%
Return on Equity (TTM) 1.62%

Valuation

Trailing PE 76.5
Forward PE -
Enterprise Value 1.26B
Price to Sales(TTM) 0.07
Enterprise Value 1.26B
Price to Sales(TTM) 0.07
Enterprise Value to Revenue 0.95
Enterprise Value to EBITDA 6.02
Shares Outstanding 30.14M
Shares Floating 27.44M
Shares Outstanding 30.14M
Shares Floating 27.44M
Percent Insiders 3.97
Percent Institutions 78.57

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.